PREVENTION OF HIV-INFECTION WITH TMC278

This invention relates to the use of a parenteral formulation comprising the NNRTI TMC278 for the long term prevention of HIV infection in a subject at risk of being infected by HIV, which comprises the intermittent administration of the said formulation at long time intervals.

Saved in:
Bibliographic Details
Main Authors HEERES, JAN, LEWI, PAULUS JOANNES, BAERT, LIEVEN ELVIRE COLETTE
Format Patent
LanguageEnglish
French
Published 12.10.2006
Subjects
Online AccessGet full text

Cover

Loading…